Anzeige
Mehr »
Login
Dienstag, 14.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Das 13-Millionen-Unternehmen mit einer Monster-Entdeckung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
457 Leser
Artikel bewerten:
(2)

Lund's Fisheries Inc.: Lund's Fisheries Achieves International Accreditation to Conduct In-House Microbiological Inspections Following Major Investments

Finanznachrichten News

CAPE MAY, NJ / ACCESSWIRE / September 27, 2022 / Lund's Fisheries is now accredited to conduct its own food safety inspections on all seafood that the company harvests, processes, and ships. The company's in-house lab equipment and testing protocols, built out over the last year, have met internationally recognized standards, and can now be used to test all Lund's products before going directly to consumers.

Before being sold, seafood products are required to be tested for microbiological contaminants such as E. coli, listeria, and salmonella. Usually, the products are sent to third-party laboratories to conduct the tests; few seafood companies in the U.S. have the capability to test their own products. To develop this capacity for itself, Lund's Fisheries set out last summer to build out its testing capabilities, aligning them with international best standards and practices and finally getting them officially accredited this month.

"This accreditation recognizes our dedication to the quality and safety of our seafood," said Joshua Farinella, Lund's Director of Compliance and Quality Assurance. "Lund's now has direct control over the full chain of custody, so we can guarantee that any product meets our high standards from the boat to the plate."

Lund's Fisheries Inc., Tuesday, September 27, 2022, Press release picture

A Lund's Fisheries employee prepares to test for vibrio at the company's newly accredited inspection facility.

The lab was accredited by independent third-party Perry Johnson Laboratory Accreditation, Inc., based on international standards set forth by the International Organization for Standardization and the International Electrotechnical Commission (ISO/IEC 17025). The accreditation process tested all facets of the inspection process: not only does the accreditation validate the equipment used in the inspections, but it also looks at lab procedures, chain of custody protocols, staff proficiency, and other factors necessary for a well-regulated testing program. Lund's lab at its Cape May, New Jersey facility has been confirmed to meet all those standards.

Conducting accredited, in-house food safety inspections is one of the many steps Lund's has taken to ensure the quality of its products. Several of the fisheries that the company participates in, such as Atlantic sea scallops, scup, and loligo and illex squid, have been certified as sustainable by the Marine Stewardship Council, the most rigorous international seafood certification available.

About Lund's Fisheries Inc.
Lund's Fisheries, Inc. is a third-generation, family-owned company and a primary producer of fresh and frozen seafood located in Cape May, N.J. Lund's purchases, produces and distributes nearly 75 million pounds of fresh and frozen fish annually. Its fresh and frozen domestic sales stretch nationwide while its frozen exports extend to markets around the world. Lund's Fisheries is committed to developing and managing systems and practices to fish within sustainable limits and track its products back to the harvest location to ensure they are sourced from fisheries that are well-managed, certified as sustainable or actively working towards implementing more responsible and sustainable harvesting practices.

Press Contact:
Bob Vanasse
Stove Boat Communications
(202) 333-2628
bob@stoveboat.com

SOURCE: Lund's Fisheries Inc.



View source version on accesswire.com:
https://www.accesswire.com/717686/Lunds-Fisheries-Achieves-International-Accreditation-to-Conduct-In-House-Microbiological-Inspections-Following-Major-Investments

© 2022 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.